Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material:
SEC Accession No. 0001013594-21-000418
Filing Date
2021-04-22
Accepted
2021-04-22 17:08:26
Documents
4

Document Format Files

Seq Description Document Type Size
1 adverumdfan14a-042221.htm DFAN14A 8947
2 EXHIBIT 99.1 adverumdfan14a-042221.pdf DFAN14A 3864679
3 adverumex992-042221.htm EX-99.2 21155
4 image00001.jpg GRAPHIC 6188
  Complete submission text file 0001013594-21-000418.txt   5333486
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Subject) CIK: 0001501756 (see all company filings)

EIN.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 001-36579 | Film No.: 21845576
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 400 HOBRON LANE, SUITE 3709 HONOLULU HI 96815
Business Address 400 HOBRON LANE, SUITE 3709 HONOLULU HI 96815 808-375-0568
Sonic Fund II, L.P. (Filed by) CIK: 0001771377 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A